Aparito has again been shortlisted in the Best Digital Health Solution category at the 2023 Prix Galien UK Awards for our clinical trial platform, Atom5™!
The Prix Galien is UK life sciences’ most prestigious award for innovation and Aparito appears amongst a field of digital health luminaries including Behold.ai Technologies Limited, Huma Therapeutics and
uMotif limited.
To be shortlisted for the Prix Galien UK Awards is a thrilling milestone for the whole team and further recognition of our collective mission to bring clinical trials to patients, from ultra rare genetic diseases to others such as Long COVID which impact thousands.
Dr Elin Haf Davies, CEO of Aparito
The Prix Galien UK Awards launched in 1990 and have been awarded to 36 products since its inception. Winners are selected every two years by the Prix Galien UK Awards Committee, which is comprised of 14 experts in the field. The Committee comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.
The winner will be announced during the Prix Galien UK Awards ceremony which takes place May 11 2023 at London’s Natural History Museum.